openPR Logo
Press release

Benign Prostatic Hyperplasia Treatment Market Size, Demand, Competitive Analysis, Regional Growth and Forecast by 2026

06-02-2022 05:54 AM CET | Health & Medicine

Press release from: IMARC Group

Benign Prostatic Hyperplasia Treatment Market Size, Demand,

According to IMARC Group's latest report, titled "Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global benign prostatic hyperplasia treatment market reached a value of US$ 10.5 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.6% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-market/requestsample

Benign prostatic hyperplasia (BPH) refers to non-cancerous growth of the prostate gland that causes urethra blockage. This disorder generally results in the retention of urine, formation of bladder stones, incontinence due to overfilling, increased sensitivity of the bladder, and urinary tract infections. Some commonly used treatment methods for BPH include prescription drugs, mono drug and combination therapy, Phyto-therapies, and minimally-invasive (MI) and invasive surgeries. Resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants are some of the standard instruments used in BPH treatment surgeries.

Market Trends and Drivers:

The rising prevalence of urological disorders across the globe, coupled with the growing geriatric population, is currently driving the benign prostatic hyperplasia treatment market growth. Furthermore, the increasing consumer awareness towards the availability of efficient and minimally-invasive treatment procedures for BPH is also propelling the market. Moreover, various advancements in the medical sector have led to the development of transurethral resection of the prostate (TURP) as an efficient treatment technique. TURP is an endoscopic electrosurgical procedure that removes a portion of the prostate gland to reduce the obstruction caused by abnormal growth. In addition to this, the rising healthcare expenditures and improving healthcare infrastructures will continue to drive the market growth in the coming years.

Benign Prostatic Hyperplasia Treatment Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the benign prostatic hyperplasia treatment market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Abbott Laboratories
GlaxoSmithKline Plc
Boston Scientific Corporation
Pfizer Inc.
Asahi Kasei Corporation
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Allergan Plc (AbbVie Inc.)
Astellas Pharma Inc.
Boehringer Ingelheim GmbH (C.H. Boehringer Sohn AG & Ko. KG)

Key Market Segmentation:

The report has segmented the global benign prostatic hyperplasia treatment market on the basis of treatment and region.

Market Breakup by Treatment:

Drug Class
Alpha-Blockers
5-Alpha-reductase Inhibitors (5-ARIs)
Phosphodiesterase-5 Enzyme Inhibitors
Others
Minimally Invasive Surgeries
Transurethral Resection of the Prostate (TURP)
Transurethral Incision of the Prostate (TUIP)
Transurethral Microwave Thermotherapy (TUMT)
Robotic Surgeries
Prostatic Urethral Lifts
Others
Laser Therapy
Others

Market Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2898&flag=C
Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostatic Hyperplasia Treatment Market Size, Demand, Competitive Analysis, Regional Growth and Forecast by 2026 here

News-ID: 2643148 • Views: โ€ฆ

More Releases from IMARC Group

Saudi Arabia Gaming Market to Reach USD 4,738.5 Million by 2033, Industry Growing at 8.9% CAGR - Research Report
Saudi Arabia Gaming Market to Reach USD 4,738.5 Million by 2033, Industry Growin โ€ฆ
๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š ๐†๐š๐ฆ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ ๐๐š๐ฌ๐ž ๐˜๐ž๐š๐ซ: 2024 ๐‡๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐œ๐š๐ฅ ๐˜๐ž๐š๐ซ๐ฌ: 2019-2024 ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐˜๐ž๐š๐ซ๐ฌ: 2025-2033 ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: ๐”๐’๐ƒ ๐Ÿ,๐Ÿ๐Ÿ—๐Ÿ.๐Ÿ” ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘: ๐”๐’๐ƒ ๐Ÿ’,๐Ÿ•๐Ÿ‘๐Ÿ–.๐Ÿ“ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐š๐ญ๐ž: ๐Ÿ–.๐Ÿ—% (๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘) The Saudi Arabia gaming market was valued at ๐”๐’๐ƒ ๐Ÿ,๐Ÿ๐Ÿ—๐Ÿ.๐Ÿ” ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024 and is projected to grow to ๐”๐’๐ƒ ๐Ÿ’,๐Ÿ•๐Ÿ‘๐Ÿ–.๐Ÿ“ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2033, with an expected compound annual growth rate (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ–.๐Ÿ—% from 2025-2033. ๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š ๐†๐š๐ฆ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ: The gaming market in Saudiโ€ฆ
UAE Health Insurance Market to Reach USD 14.9 Billion by 2033, Industry Growing at 6.1% CAGR - Research Report
UAE Health Insurance Market to Reach USD 14.9 Billion by 2033, Industry Growing โ€ฆ
๐”๐€๐„ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘ โ€ข ๐”๐€๐„ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž (๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’): The UAE health insurance market size reached ๐”๐’๐ƒ ๐Ÿ–.๐Ÿ• ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024. โ€ข ๐”๐€๐„ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ (๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘): The market is expected to grow to ๐”๐’๐ƒ ๐Ÿ๐Ÿ’.๐Ÿ— ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2033. โ€ข ๐”๐€๐„ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐š๐ญ๐ž: The market is anticipated to exhibit a ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ”.๐Ÿ% during the forecast period from 2025 to 2033. ๐”๐€๐„ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ: The market for health insuranceโ€ฆ
Saudi Arabia Health Insurance Market to Reach USD 12.5 Billion by 2033, Industry Growing at 5.14% CAGR
Saudi Arabia Health Insurance Market to Reach USD 12.5 Billion by 2033, Industry โ€ฆ
๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘ According to IMARC Group's report titled "๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž (๐ˆ๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐š๐ฅ, ๐†๐ซ๐จ๐ฎ๐ฉ), ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž ๐๐ซ๐จ๐ฏ๐ข๐๐ž๐ซ (๐๐ฎ๐›๐ฅ๐ข๐œ, ๐๐ซ๐ข๐ฏ๐š๐ญ๐ž) ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘", the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights. ๐‡๐จ๐ฐ ๐๐ข๐  ๐ข๐ฌ ๐ญ๐ก๐ž ๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ? The Saudi Arabia health insurance market was valued at ๐”๐’๐ƒ ๐Ÿ•.๐Ÿ– ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024 and is projected to growโ€ฆ
UAE Pharmaceutical Market Size Worth USD 8.02 Billion by 2033 | CAGR: 7.30%
UAE Pharmaceutical Market Size Worth USD 8.02 Billion by 2033 | CAGR: 7.30%
๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง ๐”๐€๐„ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: ๐‡๐จ๐ฐ ๐๐ข๐  ๐ข๐ฌ ๐ญ๐ก๐ž ๐”๐€๐„ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ? The UAE pharmaceutical market size was valued at ๐”๐’๐ƒ ๐Ÿ’.๐Ÿ๐Ÿ“ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’. Looking forward, IMARC Group estimates the market to reach ๐”๐’๐ƒ ๐Ÿ–.๐ŸŽ๐Ÿ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘, exhibiting a CAGR of ๐Ÿ•.๐Ÿ‘๐ŸŽ% from 2025-2033. ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ ๐๐š๐ฌ๐ž ๐˜๐ž๐š๐ซ: 2024 ๐‡๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐œ๐š๐ฅ ๐˜๐ž๐š๐ซ๐ฌ: 2019-2024 ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐˜๐ž๐š๐ซ๐ฌ: 2025-2033 ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: ๐”๐’๐ƒ ๐Ÿ’.๐Ÿ๐Ÿ“ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘: ๐”๐’๐ƒ ๐Ÿ–.๐ŸŽ๐Ÿ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘: ๐Ÿ•.๐Ÿ‘๐ŸŽ% ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐žโ€ฆ

All 5 Releases


More Releases for Benign

Benign Prostatic Hyperplasia Therapeutics Market Clinical Survey Report 2020
The Benign Prostatic Hyperplasia Therapeutics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Click the linkโ€ฆ
Benign prostatic hyperplasia: BPH drugs versus Dr Allenโ€™s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025. Thermobalancing therapy with Dr Allenโ€™s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allenโ€™s Device.โ€ฆ
Cold Plasma Market Benign Rate by 2025
Global Cold Plasma Market: Snapshot Cold plasma, additionally called non-warm plasma or non-balance plasma, is a sort of plasmaโ€”ordinarily known as the fourth condition of issueโ€”which has gas particles show at direct temperature and electrons at moderately high temperatures. The properties of plasma have been widely looked into in the course of recent decades and an extensive number of front line utilizations of cold plasma innovation has exuded. Cold plasma isn't inโ€ฆ
Benign Prostatic Hyperplasia Therapeutics Market Epidemiology Analysis, Therapy, โ€ฆ
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grantsโ€ฆ
Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market
ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports. This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices. Topics Covered Include: An overview of device-based and pharmacological therapies for BPH and prostatitis. Global and country/region-specific market forecasts, including forecasts by product segment. Competitive analysesโ€ฆ
Benign Prostatic Hyperplasia Therapeutics Development Pipeline Overview for H1 2 โ€ฆ
2017 Benign Prostatic Hyperplasia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746 Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, aโ€ฆ